Abstract

Platelets are involved in a variety of diseases, making their adequate functional assessment is essential. However, due to their easily activatable nature this has some methodological pitfalls. Therefore, the availability of stable, easily measurable surrogate markers would be beneficial. In this regard, some evidence suggests that certain microRNAs (miRNAs) circulating in plasma might be useful. We aimed to corroborate their suitability by analyzing plasma samples obtained in a randomized controlled trial, which assessed the effects of periodontal treatment on platelet function. We hypothesized that miRNA levels mirror changes of platelet activation and -function. Both platelet function and miRNA abundance were quantified using state-of-the-art flow cytometry and qPCR methods. The following miRNAs were quantified: 223-3p, 150-5p, 197-3p, 23a-3p, 126-3p, 24-3p, 21-5p, 27b-3p, 33a-5p, 320a, 191-5p, 28-3p, 451a, 29b-3p, and 1-3p. However, periodontal treatment did not affect the abundance of any investigated miRNAs to a relevant extent. Platelet activation and reactivity indices did neither correlate with any tested miRNA at baseline, nor after the treatment period. In addition, there was no evidence that investigated miRNAs were released by platelets, as suggested previously. In conclusion, our data suggest that in patients suffering from periodontal disease the investigated miRNAs are unlikely to be suitable biomarkers for platelet function. Our data aim to raise awareness that previously determined platelet activation dependent circulating miRNAs are not suitable as platelet biomarkers in all cohorts.

Highlights

  • Platelets play a crucial role in hemostasis (Semple et al, 2011), immune responses (Kral et al, 2016), host defense (Yeaman and Bayer, 2013), and atherogenesis (Lievens and von Hundelshausen, 2011)

  • Despite clear effects of periodontal treatment on platelet activation, we found no relevant effects on several plasma miRNAs in this study

  • In line with the above-stated results there were no relevant correlations between miRNA abundance and basal platelet activation measured by surface P-selectin expression

Read more

Summary

Introduction

Platelets play a crucial role in hemostasis (Semple et al, 2011), immune responses (Kral et al, 2016), host defense (Yeaman and Bayer, 2013), and atherogenesis (Lievens and von Hundelshausen, 2011). More stable surrogate markers for platelet activation, e.g., in plasma, could provide an attractive alternative. In this context, circulating microRNAs (miRNAs) could be of interest as some have recently been shown to correlate with platelet activation and function (Nagalla et al, 2011; Sunderland et al, 2017) and might be used as biomarkers (Willeit et al, 2013). MiR-126 was found to affect platelet adhesion, degranulation, and thromboxane A2-generation (Kaudewitz et al, 2016) Given this body of evidence, an association between platelet function and the amount of certain circulating miRNA seems plausible. We analyzed the robustness of miRNAs as markers of platelet function

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.